Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial Damage

Objective. To investigate the efficacy of subhypothermia in the treatment of neonatal hypoxic-ischemic encephalopathy (HIE) combined with myocardial damage. Methods. 136 children with HIE and myocardial damage admitted to our hospital from October 2019 to October 2021 were included in the study and...

Full description

Saved in:
Bibliographic Details
Main Authors: XiaoPing Dang, XiaoJian Hu, Xun Jiang, WeiGuo Chen, YuanCui Meng, Qi Pan, Fen Yang
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Adsorption Science & Technology
Online Access:http://dx.doi.org/10.1155/2022/2465490
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841563544696389632
author XiaoPing Dang
XiaoJian Hu
Xun Jiang
WeiGuo Chen
YuanCui Meng
Qi Pan
Fen Yang
author_facet XiaoPing Dang
XiaoJian Hu
Xun Jiang
WeiGuo Chen
YuanCui Meng
Qi Pan
Fen Yang
author_sort XiaoPing Dang
collection DOAJ
description Objective. To investigate the efficacy of subhypothermia in the treatment of neonatal hypoxic-ischemic encephalopathy (HIE) combined with myocardial damage. Methods. 136 children with HIE and myocardial damage admitted to our hospital from October 2019 to October 2021 were included in the study and were divided into study group and control group of 68 cases each according to the random number table method. The control group was given conventional treatment, and the study group was treated with subhypothermia therapy on top of the control group. Comparing the effects of treatment between the two groups. The serum levels of S-100β protein, Tau protein, neuron-specific enolase (NSE), creatine kinase (CK), creatine kinase isoenzyme MB (CK-MB), lactate dehydrogenase (LDH), alpha-hydroxybutyrate dehydrogenase (ɑ-HBDH), myoglobin (Myo), cardiac trophic factor-1 (CT-1), cardiac troponin I (cTnI), superoxide dismutase (SOD), reactive oxygen species (ROS), glutathione peroxidase (GSH-Px), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-ɑ (TNF-ɑ) were measured in both groups before and after treatment, respectively. Results. The total effective rate was higher in the study group (88.24%) than in the control group (72.06%) (P<0.05). After treatment, the serum levels of S-100β protein, Tau protein, NSE, CK, CK-MB, LDH, ɑ-HBDH, Myo, CT-1, cTnI, ROS, IL-1β, IL-8, and TNF-ɑ were reduced in both groups, and the study group was lower than the control group (P<0.05). The serum levels of SOD and GSH-Px were higher in both groups after treatment than before treatment and were higher in the study group than in the control group (P<0.05). Conclusion. Subhypothermia treatment of children with HIE combined with myocardial injury can further improve the hypoxic-ischemic state; reduce myocardial damage, oxidative stress, and inflammatory response; and has a good overall efficacy.
format Article
id doaj-art-898b136bad4b4349b8df0633f4845c4c
institution Kabale University
issn 2048-4038
language English
publishDate 2022-01-01
publisher SAGE Publishing
record_format Article
series Adsorption Science & Technology
spelling doaj-art-898b136bad4b4349b8df0633f4845c4c2025-01-02T23:45:02ZengSAGE PublishingAdsorption Science & Technology2048-40382022-01-01202210.1155/2022/2465490Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial DamageXiaoPing Dang0XiaoJian Hu1Xun Jiang2WeiGuo Chen3YuanCui Meng4Qi Pan5Fen Yang6Department of NeonataDepartment of UrologyDepartment of NeonataDepartment of Cardiovascular MedicineDepartment of NeonataDepartment of RadiologyDepartment of NeonataObjective. To investigate the efficacy of subhypothermia in the treatment of neonatal hypoxic-ischemic encephalopathy (HIE) combined with myocardial damage. Methods. 136 children with HIE and myocardial damage admitted to our hospital from October 2019 to October 2021 were included in the study and were divided into study group and control group of 68 cases each according to the random number table method. The control group was given conventional treatment, and the study group was treated with subhypothermia therapy on top of the control group. Comparing the effects of treatment between the two groups. The serum levels of S-100β protein, Tau protein, neuron-specific enolase (NSE), creatine kinase (CK), creatine kinase isoenzyme MB (CK-MB), lactate dehydrogenase (LDH), alpha-hydroxybutyrate dehydrogenase (ɑ-HBDH), myoglobin (Myo), cardiac trophic factor-1 (CT-1), cardiac troponin I (cTnI), superoxide dismutase (SOD), reactive oxygen species (ROS), glutathione peroxidase (GSH-Px), interleukin-1β (IL-1β), interleukin-8 (IL-8), and tumor necrosis factor-ɑ (TNF-ɑ) were measured in both groups before and after treatment, respectively. Results. The total effective rate was higher in the study group (88.24%) than in the control group (72.06%) (P<0.05). After treatment, the serum levels of S-100β protein, Tau protein, NSE, CK, CK-MB, LDH, ɑ-HBDH, Myo, CT-1, cTnI, ROS, IL-1β, IL-8, and TNF-ɑ were reduced in both groups, and the study group was lower than the control group (P<0.05). The serum levels of SOD and GSH-Px were higher in both groups after treatment than before treatment and were higher in the study group than in the control group (P<0.05). Conclusion. Subhypothermia treatment of children with HIE combined with myocardial injury can further improve the hypoxic-ischemic state; reduce myocardial damage, oxidative stress, and inflammatory response; and has a good overall efficacy.http://dx.doi.org/10.1155/2022/2465490
spellingShingle XiaoPing Dang
XiaoJian Hu
Xun Jiang
WeiGuo Chen
YuanCui Meng
Qi Pan
Fen Yang
Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial Damage
Adsorption Science & Technology
title Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial Damage
title_full Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial Damage
title_fullStr Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial Damage
title_full_unstemmed Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial Damage
title_short Clinical Efficacy of Subhypothermia in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy Combined with Myocardial Damage
title_sort clinical efficacy of subhypothermia in the treatment of neonatal hypoxic ischemic encephalopathy combined with myocardial damage
url http://dx.doi.org/10.1155/2022/2465490
work_keys_str_mv AT xiaopingdang clinicalefficacyofsubhypothermiainthetreatmentofneonatalhypoxicischemicencephalopathycombinedwithmyocardialdamage
AT xiaojianhu clinicalefficacyofsubhypothermiainthetreatmentofneonatalhypoxicischemicencephalopathycombinedwithmyocardialdamage
AT xunjiang clinicalefficacyofsubhypothermiainthetreatmentofneonatalhypoxicischemicencephalopathycombinedwithmyocardialdamage
AT weiguochen clinicalefficacyofsubhypothermiainthetreatmentofneonatalhypoxicischemicencephalopathycombinedwithmyocardialdamage
AT yuancuimeng clinicalefficacyofsubhypothermiainthetreatmentofneonatalhypoxicischemicencephalopathycombinedwithmyocardialdamage
AT qipan clinicalefficacyofsubhypothermiainthetreatmentofneonatalhypoxicischemicencephalopathycombinedwithmyocardialdamage
AT fenyang clinicalefficacyofsubhypothermiainthetreatmentofneonatalhypoxicischemicencephalopathycombinedwithmyocardialdamage